Tweet
The 3 Marijuana stocks that I feel have the best chances for success are as follows. Many people are concerned that Mr TRUMP could ruin the Marijuana Industry in the U.S. Not to worry here, because the 3 firms mentioned below are "ALL CANADIAN!" Folks please be aware that the following 3 stocks are "Highly Speculative" and can make violent moves in either direction. Only place money into these stocks that you can afford to lose, although in my opinion the UPSIDE Profits that could be made over time could be HUGE! Basically you put your money down and take your chances! Good Luck To All!
1.. TWMJF Canopy Growth Corporation Chart: http://schrts.co/lghzLi Folks Check out the performance of $10,000 put into TWMJF in early 2014 ......Truly AMAZING! http://performance.morningstar.com/s...&culture=en_US
TWMJF is a Vancouver-based company sometimes called the "New King of Pot Stocks" because it’s positioned as the future monopoly of Canada’s marijuana industry. The following information was obtained from the internet!
"The Canadian market for medical marijuana is growing fast.
Industry experts project the market will grow from 40,000 individuals to 1 million in just a few years.
And TWMJF is THE number one way to cash in on Canada’s explosive market — hands down.
First off, the company is Canada’s first licensed marijuana distributer and manufacturer, so it has considerable first-mover advantage.
That alone should grab our attention.
But when you add a recent acquisition of its biggest competitor...
A combination that analysts hail as “a cannabis superpower”...
We can now indisputably say it’s the dominant player of the country’s market — one that will lead this industry from infancy to maturity...
And deliver investors the biggest returns.
But it has just started growing its market share, and here’s why...
The company doubled its revenue each month in 2014.
In 2015, its revenues have grown six-fold.
In just two short years, its revenues are projected to explode 2,900%... even as expenses decline!
No surprise, then, that it recently booked positive profits... AND free cash flow."
TWMJF is UP 298% Year To Date , and is also up a HUGE 65% for the month!!
2. SPRWF Supreme Pharmaceuticals! Also Trades on the Canadain Stock Exchange Symbol CSE:SL Chart: http://schrts.co/qUh6Ku Watch how a $10,000 stake in SPRWF grew: http://performance.morningstar.com/s...&culture=en_US
" The Toronto Globe and Mail, show that, even without complete legalization – which is being touted by Prime Minister Pierre Trudeau – the medical cannabis business should hit about $1.5 billion in the next four years. It will be significantly higher if Canada completely legalizes cannabis. Simple division means each firm could pick up about $416 million over that timeframe. Supreme Pharmaceuticals is the only grower operating a business-to-business (B2B) model. It doesn’t retail its product. Instead it sells to other companies that then sell into the regulated retail market. This is a pure growth-based weed stock. Right now, dispensaries are getting their Marijuana from licensed growers like Supreme as well as local, unlicensed growers. It’s very likely that both the regulated weed companies as well as the government would like to rein in the independent growers, since they compete with the new licensed weed companies while at the same time representing a potential huge source of revenue for the government. The smaller independent growers will likely see some limitations placed on the size and scope of their operations, so they won’t be crushed so much as contained. Otherwise, the independents would have an unfair pricing advantage since they’d be free from the costly regulatory standards the licensed companies have to operate under. Supreme is focused on national distribution channels and long-term contracts, which would lock in prices for retailers and help them to manage their profitability better. Also, Supreme offers recognized brands of weed and will “white label” as well. That means that any retailer who wants to sell his or her own ‘house’ brand, can buy weed from Supreme, and call it whatever they like. Supreme is only interested in the sale of its harvests, not consumer branding. That strategy also means it won’t have to deal with additional advertising costs as the market expands, because it won’t have to worry about branding. Retailers bear that expense.
Supreme’s actual growing is carried out by its subsidiary, 7 Acres. The name refers to the actual size of the “footprint” – 342,000 square feet of grow space – its greenhouses occupy. The company is located northwest of Toronto near the banks of Lake Huron, a short drive to Toronto or Detroit. And because of its proximity to the Great Lakes, it can ship by boat, saving transit costs and helping maximize margins. Also, its proximity to large urban areas in the U.S. means, the company can benefit from medical tourism today and from recreational tourism tomorrow should cannabis be legalized completely. In late June, while waiting on its dried marijuana sales license, Supreme made its first sale of six genetic strains of its production. That’s an encouraging indication that Supreme Pharmaceuticals has a sharp sales team and that its product is stirring interest in the market."
SPRWF is UP 288% Year To Date and UP 47% for the month!
3. OGRMF Toronto Stock Exchange = TSX:OGI Chart: http://schrts.co/ZMhlhq Morningstar Performance : (Growth Of $10,000) Since 2014! http://performance.morningstar.com/s...&culture=en-US
"OrganiGram is a licensed , "Organic" Canadian Marijuana grower. Based in New Brunswick, OrganiGram is one of the few Atlantic side growers, most of which began in the West and Pacific regions, since the weather tends to be more moderate and conducive to year-round growth. But its location – very close to Quebec, Nova Scotia, Prince Edward Island (and Maine) gives OrganiGram access to a unique network without any significant competition. It has also made significant inroads with the first responders and veteran communities. New Brunswick borders Maine, and this is important because most U.S. states on the Eastern Seaboard don’t support medical marijuana, and so patients needing it have the option of working with Canadian doctors to get treatment in Canada. Obviously the more Americans who do that, the better things are for OrganiGram’s business. Medical tourism is becoming a big industry and there are few places lovelier than the eastern coast of Canada, especially in summer. Mashmed.com projects that more than 20 million Americans will look to go abroad for medical treatment of some kind. The industry is growing rapidly, already exceeding $100 billion. And the company is delivering on its potential. Second quarter numbers (for the quarter ending February 29) were very good indeed. Sales were up 38% compared to the same quarter last year. And net revenue per gram was up 17%. OrganiGram also saw" Positive Cash Flow" from operations during the quarter, which is significant for a young, growing firm in any industry. OrganiGram also has piqued the interest of major Canadian financial player Dundee Securities which purchased $10 million worth of special shares from OrganiGram in early June 2016. OrganiGram is expected to use the money to expand production at its grow facilities. The stock is up 304% year-to-date, but sold off a bit in February because the Canadian government recently passed a law that allows medical marijuana patients to grow their own cannabis. That hurt all publicly traded Canadian growers, but OrganiGram went on 52-week highs a couple of months later.
Remember, the market cap on this company is only $239 million, so this is a stock for the RISK-TOLERANT" only. Also, with stocks at this phase in their life-cycle, you need to be patient and watchful. By watchful I mean don’t check it every day. Review when it reports its quarterly numbers. If it continues to grow and looks like its managing its growth well, stick with it. The hope is that the company gets big enough to where you will see more institutional interest, which will help boost it price. That’s the bet, and it looks like with OrganiGram the odds are in our favor. It trades more regularly on the Toronto Stock Exchange Venture market if you want to buy directly utilizing symbol TSX: OGI
1.. TWMJF Canopy Growth Corporation Chart: http://schrts.co/lghzLi Folks Check out the performance of $10,000 put into TWMJF in early 2014 ......Truly AMAZING! http://performance.morningstar.com/s...&culture=en_US
TWMJF is a Vancouver-based company sometimes called the "New King of Pot Stocks" because it’s positioned as the future monopoly of Canada’s marijuana industry. The following information was obtained from the internet!
"The Canadian market for medical marijuana is growing fast.
Industry experts project the market will grow from 40,000 individuals to 1 million in just a few years.
And TWMJF is THE number one way to cash in on Canada’s explosive market — hands down.
First off, the company is Canada’s first licensed marijuana distributer and manufacturer, so it has considerable first-mover advantage.
That alone should grab our attention.
But when you add a recent acquisition of its biggest competitor...
A combination that analysts hail as “a cannabis superpower”...
We can now indisputably say it’s the dominant player of the country’s market — one that will lead this industry from infancy to maturity...
And deliver investors the biggest returns.
But it has just started growing its market share, and here’s why...
The company doubled its revenue each month in 2014.
In 2015, its revenues have grown six-fold.
In just two short years, its revenues are projected to explode 2,900%... even as expenses decline!
No surprise, then, that it recently booked positive profits... AND free cash flow."
TWMJF is UP 298% Year To Date , and is also up a HUGE 65% for the month!!
2. SPRWF Supreme Pharmaceuticals! Also Trades on the Canadain Stock Exchange Symbol CSE:SL Chart: http://schrts.co/qUh6Ku Watch how a $10,000 stake in SPRWF grew: http://performance.morningstar.com/s...&culture=en_US
" The Toronto Globe and Mail, show that, even without complete legalization – which is being touted by Prime Minister Pierre Trudeau – the medical cannabis business should hit about $1.5 billion in the next four years. It will be significantly higher if Canada completely legalizes cannabis. Simple division means each firm could pick up about $416 million over that timeframe. Supreme Pharmaceuticals is the only grower operating a business-to-business (B2B) model. It doesn’t retail its product. Instead it sells to other companies that then sell into the regulated retail market. This is a pure growth-based weed stock. Right now, dispensaries are getting their Marijuana from licensed growers like Supreme as well as local, unlicensed growers. It’s very likely that both the regulated weed companies as well as the government would like to rein in the independent growers, since they compete with the new licensed weed companies while at the same time representing a potential huge source of revenue for the government. The smaller independent growers will likely see some limitations placed on the size and scope of their operations, so they won’t be crushed so much as contained. Otherwise, the independents would have an unfair pricing advantage since they’d be free from the costly regulatory standards the licensed companies have to operate under. Supreme is focused on national distribution channels and long-term contracts, which would lock in prices for retailers and help them to manage their profitability better. Also, Supreme offers recognized brands of weed and will “white label” as well. That means that any retailer who wants to sell his or her own ‘house’ brand, can buy weed from Supreme, and call it whatever they like. Supreme is only interested in the sale of its harvests, not consumer branding. That strategy also means it won’t have to deal with additional advertising costs as the market expands, because it won’t have to worry about branding. Retailers bear that expense.
Supreme’s actual growing is carried out by its subsidiary, 7 Acres. The name refers to the actual size of the “footprint” – 342,000 square feet of grow space – its greenhouses occupy. The company is located northwest of Toronto near the banks of Lake Huron, a short drive to Toronto or Detroit. And because of its proximity to the Great Lakes, it can ship by boat, saving transit costs and helping maximize margins. Also, its proximity to large urban areas in the U.S. means, the company can benefit from medical tourism today and from recreational tourism tomorrow should cannabis be legalized completely. In late June, while waiting on its dried marijuana sales license, Supreme made its first sale of six genetic strains of its production. That’s an encouraging indication that Supreme Pharmaceuticals has a sharp sales team and that its product is stirring interest in the market."
SPRWF is UP 288% Year To Date and UP 47% for the month!
3. OGRMF Toronto Stock Exchange = TSX:OGI Chart: http://schrts.co/ZMhlhq Morningstar Performance : (Growth Of $10,000) Since 2014! http://performance.morningstar.com/s...&culture=en-US
"OrganiGram is a licensed , "Organic" Canadian Marijuana grower. Based in New Brunswick, OrganiGram is one of the few Atlantic side growers, most of which began in the West and Pacific regions, since the weather tends to be more moderate and conducive to year-round growth. But its location – very close to Quebec, Nova Scotia, Prince Edward Island (and Maine) gives OrganiGram access to a unique network without any significant competition. It has also made significant inroads with the first responders and veteran communities. New Brunswick borders Maine, and this is important because most U.S. states on the Eastern Seaboard don’t support medical marijuana, and so patients needing it have the option of working with Canadian doctors to get treatment in Canada. Obviously the more Americans who do that, the better things are for OrganiGram’s business. Medical tourism is becoming a big industry and there are few places lovelier than the eastern coast of Canada, especially in summer. Mashmed.com projects that more than 20 million Americans will look to go abroad for medical treatment of some kind. The industry is growing rapidly, already exceeding $100 billion. And the company is delivering on its potential. Second quarter numbers (for the quarter ending February 29) were very good indeed. Sales were up 38% compared to the same quarter last year. And net revenue per gram was up 17%. OrganiGram also saw" Positive Cash Flow" from operations during the quarter, which is significant for a young, growing firm in any industry. OrganiGram also has piqued the interest of major Canadian financial player Dundee Securities which purchased $10 million worth of special shares from OrganiGram in early June 2016. OrganiGram is expected to use the money to expand production at its grow facilities. The stock is up 304% year-to-date, but sold off a bit in February because the Canadian government recently passed a law that allows medical marijuana patients to grow their own cannabis. That hurt all publicly traded Canadian growers, but OrganiGram went on 52-week highs a couple of months later.
Remember, the market cap on this company is only $239 million, so this is a stock for the RISK-TOLERANT" only. Also, with stocks at this phase in their life-cycle, you need to be patient and watchful. By watchful I mean don’t check it every day. Review when it reports its quarterly numbers. If it continues to grow and looks like its managing its growth well, stick with it. The hope is that the company gets big enough to where you will see more institutional interest, which will help boost it price. That’s the bet, and it looks like with OrganiGram the odds are in our favor. It trades more regularly on the Toronto Stock Exchange Venture market if you want to buy directly utilizing symbol TSX: OGI
Comment